Single Ascending Dose of SAB-176
SAB-176-103
Phase 1 small_molecule active
Quick answer
Single Ascending Dose of SAB-176 for PHA1A is a Phase 1 program (small_molecule) at SAB Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SAB Biotherapeutics
- Indication
- PHA1A
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active